Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
GW572016 in Recurrent Malignant Glioma
NCT00107003Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Mar 2005
- Primary completion
- Dec 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of lapatinib in glioblastoma multiforme (GBM), Gliosarcoma (GS), sponsored by National Cancer Institute. Started Mar 2005; status: completed.
02
Drugs
lapatinib
03
Conditions
glioblastoma multiforme (GBM)Gliosarcoma (GS)
Beyond the preview
Go deeper on NCT00107003.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00107003.